XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.24.3

Revenue Recognition (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Revenue Recognition [Abstract] |
Schedule of Disaggregated Revenue |
Net Sales by Business |  |  |  |  |  |  |
| Three Months |  | Nine Months
| 2024 |  | 2023 |  | 2024 |  | 2023
MedSurg and Neurotechnology: |  |  |  |  |  |  |
Instruments | $ | 679 |  |  | $ | 620 |  |  | $ | 2,044 |  |  | $ | 1,808 |
Endoscopy | 837 |  |  | 746 |  |  | 2,383 |  |  | 2,166 |
Medical | 938 |  |  | 798 |  |  | 2,710 |  |  | 2,417 |
Neurovascular | 329 |  |  | 311 |  |  | 966 |  |  | 906 |
Neuro Cranial | 441 |  |  | 384 |  |  | 1,237 |  |  | 1,112 |
| $ | 3,224 |  |  | $ | 2,859 |  |  | $ | 9,340 |  |  | $ | 8,409 |
Orthopaedics and Spine: |  |  |  |  |  |  |
Knees | $ | 570 |  |  | $ | 515 |  |  | $ | 1,760 |  |  | $ | 1,643 |
Hips | 420 |  |  | 362 |  |  | 1,241 |  |  | 1,130 |
Trauma and Extremities | 849 |  |  | 752 |  |  | 2,511 |  |  | 2,287 |
Spine | 304 |  |  | 291 |  |  | 911 |  |  | 871 |
Other | 127 |  |  | 130 |  |  | 396 |  |  | 343 |
| $ | 2,270 |  |  | $ | 2,050 |  |  | $ | 6,819 |  |  | $ | 6,274 |
Total | $ | 5,494 |  |  | $ | 4,909 |  |  | $ | 16,159 |  |  | $ | 14,683 |
Net Sales by Geography |  |  |  |  |
| Three Months 2024 |  | Three Months 2023
| United States | International |  | United States | International
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $ | 544 |  | $ | 135 |  |  | $ | 495 |  | $ | 125 |
Endoscopy | 689 |  | 148 |  |  | 618 |  | 128 |
Medical | 783 |  | 155 |  |  | 660 |  | 138 |
Neurovascular | 121 |  | 208 |  |  | 120 |  | 191 |
Neuro Cranial | 366 |  | 75 |  |  | 315 |  | 69 |
| $ | 2,503 |  | $ | 721 |  |  | $ | 2,208 |  | $ | 651 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 417 |  | $ | 153 |  |  | $ | 385 |  | $ | 130 |
Hips | 256 |  | 164 |  |  | 231 |  | 131 |
Trauma and Extremities | 621 |  | 228 |  |  | 550 |  | 202 |
Spine | 225 |  | 79 |  |  | 217 |  | 74 |
Other | 87 |  | 40 |  |  | 87 |  | 43 |
| $ | 1,606 |  | $ | 664 |  |  | $ | 1,470 |  | $ | 580 |
Total | $ | 4,109 |  | $ | 1,385 |  |  | $ | 3,678 |  | $ | 1,231 |
Net Sales by Geography |  |  |  |  |
| Nine Months 2024 |  | Nine Months 2023
| United States | International |  | United States | International
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $ | 1,640 |  | $ | 404 |  |  | $ | 1,440 |  | $ | 368 |
Endoscopy | 1,948 |  | 435 |  |  | 1,767 |  | 399 |
Medical | 2,261 |  | 449 |  |  | 1,954 |  | 463 |
Neurovascular | 369 |  | 597 |  |  | 361 |  | 545 |
Neuro Cranial | 1,014 |  | 223 |  |  | 910 |  | 202 |
| $ | 7,232 |  | $ | 2,108 |  |  | $ | 6,432 |  | $ | 1,977 |
Orthopaedics and Spine: |  |  |  |  |
Knees | $ | 1,279 |  | $ | 481 |  |  | $ | 1,207 |  | $ | 436 |
Hips | 768 |  | 473 |  |  | 716 |  | 414 |
Trauma and Extremities | 1,842 |  | 669 |  |  | 1,663 |  | 624 |
Spine | 675 |  | 236 |  |  | 650 |  | 221 |
Other | 274 |  | 122 |  |  | 233 |  | 110 |
| $ | 4,838 |  | $ | 1,981 |  |  | $ | 4,469 |  | $ | 1,805 |
Total | $ | 12,070 |  | $ | 4,089 |  |  | $ | 10,901 |  | $ | 3,782 |
Contract with Customer, Contract Asset, Contract Liability, and Receivable | Changes in contract liabilities during the nine months 2024 were as follows:
| September 30
| 2024
Beginning contract liabilities | $ | 860 |
Revenue recognized from beginning of year contract liabilities | (382) |
Net advance consideration received during the period | 530 |
Ending contract liabilities | $ | 1,008 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration